Nabla Bio CEO Surge Biswas (L) and president Frances Anastassacos
Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs
Protein-making AI models have fueled the launch of a $1 billion startup and a Nobel Prize win in 2024, but are they ready to actually …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
